Lorazepam and Polychromasia - a phase IV clinical study of FDA data

Summary:

Polychromasia is reported as a side effect among people who take Lorazepam (lorazepam), especially for people who are male, 50-59 old, also take Zoloft, and have Metastases to bone.

The phase IV clinical study analyzes which people have Polychromasia when taking Lorazepam. It is created by eHealthMe based on reports of 161,687 people who have side effects when taking Lorazepam from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Polychromasia?

Polychromasia (abnormally high number of red blood cells found in the bloodstream) is found to be associated with 93 drugs and 166 conditions by eHealthMe. Check the latest studies of Polychromasia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

161,687 people reported to have side effects when taking Lorazepam.
Among them, 11 people (0.01%) have Polychromasia.

Among these 11 people:

What is the gender of people who have Polychromasia when taking Lorazepam? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Polychromasia when taking Lorazepam? *

What are other drugs people take besides Lorazepam? *

What are other side effects people have besides Polychromasia? *

Thrombocytopenia (decrease of platelets in blood): 5 people, 45.45%
Anisocytosis (patient's red blood cells are of unequal size): 4 people, 36.36%
Poikilocytosis (presence of poikilocytes in the blood): 4 people, 36.36%
Back Pain: 4 people, 36.36%
Delirium (wild excitement): 4 people, 36.36%
Eosinophilia (eosinophil count in the peripheral blood exceeds): 4 people, 36.36%
Fever: 4 people, 36.36%
Joint Pain: 4 people, 36.36%
Leukocytosis (increased white blood cells): 4 people, 36.36%
Neutrophilia: 4 people, 36.36%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 18.18%
Pneumonia: 2 people, 18.18%
Pain: 2 people, 18.18%
Multiple Myeloma (cancer of the plasma cells): 2 people, 18.18%
Metastases To Bone (cancer spreads to bone): 2 people, 18.18%
Breast Cancer Metastatic: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and have Polychromasia?

- Check whether Polychromasia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lorazepam:

Lorazepam (165,639 reports)

Polychromasia treatments and more:

Polychromasia (464 reports)

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Polychromasia:

Polychromasia (93 drugs)

Browse all the conditions that are associated with Polychromasia:

Polychromasia (166 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Lorazepam) and Lorazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.